The aim of the studies was to analyse reproduction of raccoon dog females, estimation of genetic and environmental variability parameters of prolificacy and other reproduction-related traits. The material for the study was represented by data obtained from breeding documentation of a fur-animal breeding farm in the Wielkopolskie Province. The data were on raccoon dogs bred during 1997-1999. The observations covered 1165 females of the breeding stock, which had given birth and their offspring had been weaned. The results of the reproduction of the females were presented in relation to: year of an observation, age of females, litter size of their origin, colour type, date of heat appearance, gestation length, and whelping date. The restricted maximum likelihood method (REML) was applied for the estimation of genetic and phenotypic reproductive traits.
Mitochondria are eukaryotic organelles that are involved in many metabolic pathways. These organelles play a major role in the process of oxidative phosphorylation (OXPHOS) and apoptosis. Genetic changes in mtDNA may disrupt these processes and lead to abnormal cell function. Abnormalities in nucleotide sequence,of mitochondrial DNA are identified as being characteristics of malignant cells. Changes observed in mtDNA can occur in the early stage of carcinogenesis. Until now, no specific mutations for type of tumor have been found in mitochondrial DNA. After many years of research of mtDNA mutations in malignant transformation, it is still not clear whether mutations present in mitochondrial DNA are primary in relation to a cancer or secondary acquired during carcinogenesis. Disclosure of mutations after a long period of occurrence (when mutated gene occurs predominantly) and slowly progressive nature of symptoms may indicate a primary character of these mutations. Despite intensive studies, the impact of mitochondria on carcinogenesis process is still not clear. Continuation of studies on relationship between mutations of mtDNA and occurrence of cancers can become the basis for identification of prognostic and diagnostic markers for early detection of malignant transformation process and development of new methods of treatments for both humans and dogs. The results of study on oncogenomics of dog, as a model animal, can be employed in the future in human medicine.